» Articles » PMID: 15133645

HLA-G and IL-10 in Serum in Relation to HLA-G Genotype and Polymorphisms

Overview
Journal Immunogenetics
Date 2004 May 11
PMID 15133645
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The expression and importance of the non-classical human leukocyte antigen (HLA) class Ib gene, HLA-G, at the feto-maternal interface have been recognized. The HLA-G molecule is almost monomorphic and expressed in both membrane-bound and soluble isoforms. It has been shown to inhibit NK-mediated cell lysis and influence cytokine expression. Recently, a possible boarder immunoregulatory function of HLA-G also in adult life has been recognized. HLA-G gene polymorphism has been linked to differences in gene expression profile of alternatively spliced HLA-G transcripts and levels of specific HLA-G mRNA isoforms. On this background it is of general interest to further elucidate any associations between HLA-G polymorphism and protein expression. We have HLA-G genotyped 85 individuals attending IVF treatment, and further studied sHLA-G1/HLA-G5 and interleukin-10 (IL-10) in serum samples. In 21% of the serum samples sHLA-G1/HLA-G5 could be detected. There was no correlation between sHLA-G1/HLA-G5 and IL-10 concentrations in serum. Soluble HLA-G1/HLA-G5 was not detected in any samples homozygous for a 14-bp insertion polymorphism in exon 8 of the 3'-untranslated region (3'UTR) of the HLA-G gene ( P=0.03; Fisher's exact test). Polymorphisms in the 5'-upstream regulatory region (5'URR) of the HLA-G gene were also studied. In conclusion, this study indicates that polymorphisms in the 3'UTR and the 5'URR of the HLA-G gene may influence the expression of sHLA-G of possible importance in pathological pregnancies and also in organ transplantation.

Citing Articles

Immune-checkpoint HLA-G gene polymorphisms, 3'-UTR types and their association with hepatocellular carcinoma and treatment response in Indian population.

Nadda N, Yadav R, Roy N, Singh N, Kumar S, Paul S Front Immunol. 2024; 15:1459749.

PMID: 39703498 PMC: 11656047. DOI: 10.3389/fimmu.2024.1459749.


The 14-bp insertion/deletion as a promising gene polymorphism to understand cancer risk: Evidence from a systematic review and comprehensive meta-analysis.

Tizaoui K, Ayadi M, Zemni I, Harrath A, Rizzo R, Boujelbene N Heliyon. 2024; 10(22):e39740.

PMID: 39605806 PMC: 11599971. DOI: 10.1016/j.heliyon.2024.e39740.


Maternal-Fetal Compatibility in Recurrent Pregnancy Loss.

Cuadrado-Torroglosa I, Garcia-Velasco J, Alecsandru D J Clin Med. 2024; 13(8).

PMID: 38673652 PMC: 11051463. DOI: 10.3390/jcm13082379.


A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G.

Mocci S, Littera R, Chessa L, Campagna M, Melis M, Ottelio C Front Immunol. 2023; 14:1138559.

PMID: 37342325 PMC: 10277491. DOI: 10.3389/fimmu.2023.1138559.


HLA-G and Recurrent Pregnancy Loss.

Barbaro G, Inversetti A, Cristodoro M, Ticconi C, Scambia G, Di Simone N Int J Mol Sci. 2023; 24(3).

PMID: 36768880 PMC: 9917226. DOI: 10.3390/ijms24032557.


References
1.
Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E . An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A. 1994; 91(10):4209-13. PMC: 43754. DOI: 10.1073/pnas.91.10.4209. View

2.
Fujii T, Ishitani A, Geraghty D . A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol. 1994; 153(12):5516-24. View

3.
Hviid T, Hylenius S, Rorbye C, Nielsen L . HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics. 2003; 55(2):63-79. DOI: 10.1007/s00251-003-0547-z. View

4.
Kapasi K, Albert S, Yie S, Zavazava N, Librach C . HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology. 2000; 101(2):191-200. PMC: 2327080. DOI: 10.1046/j.1365-2567.2000.00109.x. View

5.
Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H . Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. J Clin Immunol. 2003; 23(4):307-14. DOI: 10.1023/a:1024592901663. View